Skip to main content
Premium Trial:

Request an Annual Quote

Tepnel to Distribute SoftGenetics Software with Trisomal Dx Kits

NEW YORK (GenomeWeb News) – British medical diagnostics company Tepnel Life Sciences will market and distribute SoftGenetics’ genotyping software for use with its prenatal screening test, Tepnel said today.
Under the agreement, Tepnel will market the GeneMarker software with its Elucigene QST*R kits, which are rapid DNA diagnostic tests that use STR markers to detect three common trisomal disorders, including Down syndrome, Edwards syndrome, and Patau syndrome.
Using the GeneMarker software with the kits “will considerably streamline the data analysis process and results reporting time for users,” Tepnel said.
Tepnel is based in Manchester, UK, and it has laboratories in the US and in France. It provides tests and reagents for molecular diagnostics and biomedical research.
SoftGenetics has facilities in Stamford, Conn., and in State College, Pa., and it focuses on developing software for research and diagnostic applications.
Financial terms of the agreement were not released.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.